Warren Buffett's Berkshire Hathaway Inc said on Friday second-quarter profit fell 40 percent, as declining stock prices depressed the value of his derivative contracts.
Stocks ended lower on Friday after government data showed a much larger-than-expected drop in July payrolls, providing investors with a stark reminder the economic recovery remains slow.
Stock index futures dipped on Thursday as investors took a cautious track ahead of data on first-time jobless claims, a precursor to the monthly jobs report due later in the week.
Stock index futures slipped on Friday as investors turned cautious ahead of a report expected to show slowing growth in the U.S. economy in the second quarter.
Department of Environment and Resource Management Director General John Bradley has played down reports of hydrocarbon and possibly mercury contamination of Kogan Creek near Dalby, Queensland.
A court in Russia's far east has ordered an Internet provider to block five sites which it said disseminated extreme views, prompting U.S. Internet giant Google to say on Thursday the move restricted access to information.
Slashed outlooks from Nvidia Corp and Symantec Corp knocked chipmakers lower on Thursday, raising questions about demand for technology components and igniting a broad selloff.
Wall Street stocks fell on Wednesday as the S&P 500 struggled to break through a key technical level after an unexpected decline in durable goods orders weighed on market sentiment.
The euro hovered below a key level against the dollar on Wednesday, dented by profit-taking after it hit an 11-week high, while the Australian dollar fell as inflation data pared the chances of an interest rate rise next week.
The euro slipped below a key level against the dollar on Wednesday, dented by profit-taking after it hit an 11-week high, while the Australian dollar fell as inflation data pared the chances of an interest rate rise next week.
(Corrects spelling of company's name to Cummins in 2nd bullet point and paragraph 10 in late morning report)
Weaker-than-expected consumer confidence reversed early stock gains fueled by strong corporate earnings on Tuesday, leaving indexes slightly lower.
Stock index futures pointed to a slightly lower open on Wall Street on Monday, as investors take a breather following last week's strong gains sparked by a flurry of reassuring company earnings.
Stock index futures pointed to a slightly lower open on Wall Street on Monday, as investors take a breather following last week's strong gains sparked by a flurry of reassuring company earnings.
Gold slipped on Friday despite gains in equities as investors took to the sidelines before the release of European bank stress test results, which seek to restore confidence in the euro zone banking sector.
Major listed lenders are expected to pass, while the tests may show the biggest problems lie with smaller, mainly unlisted players like Germany's Landesbanks and Spain's cajas.
The dollar fell toward a seven-month low against the yen but world stocks recovered earlier losses on Thursday after Federal Reserve chairman Ben Bernanke painted a gloomy outlook for the U.S. economy.
Japan's Nikkei average inched down 0.2 percent on Wednesday, weighed down by worries about a stronger yen and doubts over the U.S. economic recovery as the market awaited events later this week, including the results of European bank stress tests.
BP Chief Executive Tony Hayward is to step down within the next 10 weeks, The Times reported on Wednesday.
Futures for the S&P 500, Dow Jones and Nasdaq were down 0.2 to 0.3 percent at 900 GMT (5 a.m. EDT), pointing to a lower open on Wall Street on Tuesday.
Mattel Inc reported a smaller-than-expected quarterly profit as lackluster cost-cutting and a weakening euro offset strong Hot Wheels sales and the boost the company got from merchandise tied to the blockbuster film Toy Story 3.
Mattel Inc reported a smaller-than-expected quarterly profit as the impact of the weaker euro and disappointing cost-cutting efforts offset strong Hot Wheels sales and the boost the company got from its license for the Hollywood blockbuster Toy Story 3.
The first new prescription weight-loss pill in more than a decade failed to win backing from U.S. health advisers, who said safety concerns about the drug outweighed its ability to help obese patients shed pounds.
